NCT02276508View on ClinicalTrials.gov

Open Label Trial of Nissle 1917

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Urinary Tract Infections
Interventions
DRUG

E. coli Nissle 1917

Participants will all take E. coli Nissle 1917 orally administered medication for 30 days

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Elizabeth Lucas

OTHER

NCT02276508 - Open Label Trial of Nissle 1917 | Biotech Hunter | Biotech Hunter